In March 2025, the company declared new programs for any direct-to-shopper featuring of its Wegovy weight loss drug. The company established a brand new pharmacy, termed NovoCare, which might cost clients $499 each month for use of the drug, below half the cost of the drug via other pharmaceutical distribution networks.[53]In Oct 2024, Novo Nordisk